
BRRGF
Healthcare · Biotechnology · $434.8M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 26, 2025 | Before the open | — | -0.07 | — |
| Nov 13, 2024 | Before the open | — | -0.06 | — |
| Aug 21, 2024 | Before the open | — | -0.13 | — |
| May 29, 2024 | Before the open | — | -0.13 | — |
| Mar 6, 2024 | Before the open | — | -0.00 | — |
| Feb 15, 2023 | After the close | -0.85 | -0.87 | -2.4% |
| Nov 14, 2022 | After the close | -0.82 | -0.67 | +18.3% |
| Aug 22, 2022 | After the close | -0.83 | -0.95 | -14.5% |
| May 23, 2022 | After the close | -0.78 | -0.92 | -17.9% |
| Feb 15, 2022 | After the close | -0.81 | -0.78 | +3.7% |
| Nov 15, 2021 | After the close | -1.03 | -0.80 | +22.3% |
| Aug 16, 2021 | After the close | -0.94 | -1.02 | -8.5% |
| May 18, 2021 | After the close | -0.80 | -0.93 | -16.3% |
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. The company is based in Oslo, Norway.
| Feb 9, 2021 | After the close | -0.78 | -0.85 | -9.0% |
| Nov 16, 2020 | After the close | -0.70 | -0.77 | -10.0% |
| Aug 17, 2020 | After the close | -0.65 | -0.86 | -32.3% |
| May 18, 2020 | After the close | -0.80 | -0.73 | +8.8% |
| Feb 10, 2020 | After the close | -1.61 | -0.94 | +41.6% |
| Nov 18, 2019 | After the close | -1.28 | -0.73 | +43.0% |
| Aug 18, 2019 | After the close | -0.97 | -0.94 | +3.1% |
| May 7, 2019 | After the close | -0.95 | -0.81 | +14.7% |
| Feb 11, 2019 | After the close | -0.79 | -0.92 | -16.5% |
| Nov 12, 2018 | After the close | — | -0.11 | — |
| Aug 20, 2018 | After the close | 0.00 | -0.08 | — |
| May 14, 2018 | After the close | 0.00 | -0.11 | — |
| Feb 12, 2018 | After the close | 0.00 | -0.14 | — |